BOM:500126 (India)
Â
Shs Dematerialised
₹
5,502
+67.05 (+1.23%)
Sep 18
Business Description
Procter & Gamble Health Ltd
SIC : 2834
ISIN : INE199A01012
Share Class Description:
BOM:500126: Shs DematerialisedTotal Employee Number:
1,332Compare
Compare
Traded in other countries / regions
500126.India IPO Date
1992-03-02Description
Procter & Gamble Health Ltd is an Indian pharmaceutical company that manufactures and markets branded healthcare and pharmaceutical products. It operates primarily in the vitamins, minerals and supplements segment, with a portfolio of well-known brands including Neurobion, Evion, Polybion, Livogen, Seven Seas, Nasivion, Cosome and Betamil. These products address areas such as vitamin deficiencies, anemia, respiratory care and general wellness, and are sold mainly through pharmacies, hospitals and healthcare professionals across India. The company generates the majority of its revenue domestically, with a smaller portion from international markets. It operates as a single reportable pharmaceutical segment. Procter & Gamble Health was formerly known as Merck Limited in India before its consumer health business was acquired by Procter & Gamble, and it continues to be listed on Indian stock exchanges.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 19.08 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.02 | |||||
Interest Coverage | 775 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 21.31 | |||||
Beneish M-Score | -1.9 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.2 | |||||
3-Year EBITDA Growth Rate | 19.1 | |||||
3-Year EPS without NRI Growth Rate | 18.5 | |||||
3-Year FCF Growth Rate | 34.8 | |||||
3-Year Book Growth Rate | -5.2 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.73 | |||||
9-Day RSI | 38.35 | |||||
14-Day RSI | 35.63 | |||||
3-1 Month Momentum % | -7.66 | |||||
6-1 Month Momentum % | 18.16 | |||||
12-1 Month Momentum % | -6.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.18 | |||||
Quick Ratio | 1.65 | |||||
Cash Ratio | 0.7 | |||||
Days Inventory | 123.67 | |||||
Days Sales Outstanding | 37.97 | |||||
Days Payable | 178.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.82 | |||||
Dividend Payout Ratio | 0.79 | |||||
3-Year Dividend Growth Rate | 24.2 | |||||
Forward Dividend Yield % | 2.82 | |||||
5-Year Yield-on-Cost % | 14.74 | |||||
Shareholder Yield % | 2.86 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 74.37 | |||||
Operating Margin % | 30.83 | |||||
Net Margin % | 24.91 | |||||
EBITDA Margin % | 35.93 | |||||
FCF Margin % | 3.41 | |||||
OCF Margin % | 3.64 | |||||
ROE % | 63.68 | |||||
ROA % | 42.32 | |||||
ROIC % | 76.71 | |||||
3-Year ROIIC % | 155.91 | |||||
ROC (Joel Greenblatt) % | 214.29 | |||||
ROCE % | 80.13 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 25.57 | |||||
Forward PE Ratio | 28.4 | |||||
PE Ratio without NRI | 28.09 | |||||
Shiller PE Ratio | 26.33 | |||||
Price-to-Owner-Earnings | 28.66 | |||||
PEG Ratio | 1.9 | |||||
PS Ratio | 6.37 | |||||
PB Ratio | 17.41 | |||||
Price-to-Tangible-Book | 17.43 | |||||
Price-to-Free-Cash-Flow | 28.33 | |||||
Price-to-Operating-Cash-Flow | 27.04 | |||||
EV-to-EBIT | 18.28 | |||||
EV-to-EBITDA | 17.41 | |||||
EV-to-Revenue | 6.26 | |||||
EV-to-FCF | 27.34 | |||||
Price-to-GF-Value | 1.08 | |||||
Price-to-Projected-FCF | 3.61 | |||||
Price-to-Median-PS-Value | 0.9 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.22 | |||||
Price-to-Graham-Number | 4.65 | |||||
| Price-to-Net-Current-Asset-Value | 38.14 | |||||
Earnings Yield (Greenblatt) % | 5.48 | |||||
FCF Yield % | 3.54 | |||||
Forward Rate of Return (Yacktman) % | 17 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Procter & Gamble Health Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 14,079.7 | ||
| EPS (TTM) (₹) | 196.941 | ||
| Beta | 0.3533 | ||
| 3-Year Sharpe Ratio | 0.04 | ||
| 3-Year Sortino Ratio | 0.06 | ||
| Volatility % | 26.88 | ||
| 14-Day RSI | 35.63 | ||
| 14-Day ATR (₹) | 115.950088 | ||
| 20-Day SMA (₹) | 5637.1625 | ||
| 12-1 Month Momentum % | -6.94 | ||
| 52-Week Range (₹) | 4699.7 - 6955 | ||
| Shares Outstanding (Mil) | 16.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Procter & Gamble Health Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Procter & Gamble Health Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Procter & Gamble Health Ltd Frequently Asked Questions
What is Procter & Gamble Health Ltd(BOM:500126)'s stock price today?
The current price of BOM:500126 is ₹5502.00. The 52 week high of BOM:500126 is ₹6955.00 and 52 week low is ₹4699.70.
When is next earnings date of Procter & Gamble Health Ltd(BOM:500126)?
The next earnings date of Procter & Gamble Health Ltd(BOM:500126) is .
Does Procter & Gamble Health Ltd(BOM:500126) pay dividends? If so, how much?
The Dividend Yield %  of Procter & Gamble Health Ltd(BOM:500126) is 2.82% (As of Today), Highest Dividend Payout Ratio of Procter & Gamble Health Ltd(BOM:500126) was 0.79. The lowest was 0.15. And the median was 0.4. The  Forward Dividend Yield % of Procter & Gamble Health Ltd(BOM:500126) is 2.82%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers